Antonio C. Wolff and Mikala Egeblad were named co-directors of the Breast and Gynecologic Cancer Program at Johns Hopkins Kimmel Cancer Center.xxx:moreWolff and Egebl
Joseph Contessa was named chair of radiation oncology for Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School, and Rutgers New Jersey Medical School. He will also serve as associate director for translational research at Rutgers Cancer Institute.
Jaime LaMontagne was appointed chief marketing officer of Astrin Biosciences.
Mailing a stool-based test directly to people’s homes was the most effective of four strategies for increasing colorectal cancer screening rates, according to a study by UCLA researchers aimed at identifying the best approach to promote CRC screening in adults ages 45 to 49.
EPCORE FL-1 phase III trial results show that subcutaneous epcoritamab in combination with rituximab and lenalidomide reduced the risk of disease progression or death by 79% for patients with relapsed/refractory follicular lymphoma.
FDA granted accelerated approval for Modeyso (dordaviprone) for the treatment of adult and pediatric patients (1 year of age and older) with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy.
In 1999, Rick Pazdur went in for a “perfunctory” final interview at FDA. Thinking it would only take a few minutes, his wife, Mary, decided to wait and have a quick cup of coffee at a nearby restaurant—Hooters.
We recently had the privilege of contributing to a CBS Sunday Morning story on the ongoing crisis in the federal support for research in general and cancer research in particular.
Since early May, a group of current and former NIH employees have gathered every Saturday at the Medical Center Metro station in Bethesda, MD, to mourn what they describe as the loss of scientific progress under the Trump administration.xxx:more
When the Women’s Health Initiative was announced in 1991, it was set to be the largest women’s health study ever conducted. The WHI scope is massive: the initiative has recruited more than 161,000 women and engaged more than 5,000 scientists from the U.S. and beyond.
